Rapier Pharmaceutical Private Limited

Rapier Pharmaceutical Private Limited - pharma in Rajkot, Gujarat, India. FY 2026 financials & compliance.
CIN U24230GJ2011PTC065359 Incorporated 09 May 2011 ROC Ahmedabad HQ Rajkot, Gujarat, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹12.29 Lakh
▼ 16% YoY
Net loss · FY 2025
₹4,770
Net margin -0.4%
EBITDA · FY 2025
₹25,500
EBITDA margin 2.1%
Authorised capital
₹6 Lakh
Registered with MCA
Paid-up capital
₹4.9 Lakh
Issued & subscribed
Company age
15 yrs
Est. 2011
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered

About Rapier Pharmaceutical Private Limited

Data last updated:

Rapier Pharmaceutical Private Limited is a private limited company based in Rajkot, Gujarat, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 09 May 2011 and has been in existence for over 15 years.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ2011PTC065359. Its GSTIN is 24AAFCR3378A1ZN (Gujarat).

The company has an authorised share capital of ₹6 Lakh and a paid-up capital of ₹4.9 Lakh. It is led by directors including Hanishbhai Mansukhlal Buddhdev and Jitendrakumar Jayvantbhai Panchamiya.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No – 9 Upper Level Orbit Centre Moti Tanki Chowk, Rajkot, Gujarat, India – 360001.

As per the financials filed for FY 2025, the company reported a revenue of ₹12.29 Lakh, a decline of 16% compared to the previous year. For the same year it recorded a net loss of ₹4,770 (net margin -0.4%) and EBITDA of ₹25,500 (EBITDA margin 2.1%). Revenue has declined at a compounded annual rate (CAGR) of 11% over three years and 10% over five years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Rapier Pharmaceutical Private Limited
CIN U24230GJ2011PTC065359
Registration Number 065359
Incorporation Date 09 May 2011
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    Shop No – 9 Upper Level Orbit Centre Moti Tanki Chowk, Rajkot, Gujarat, India – 360001
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Rapier Pharmaceutical Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Rapier Pharmaceutical Private Limited report

Financials, compliance, directors, charges, ownership and filings for Rapier Pharmaceutical Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Rapier Pharmaceutical Private Limited

The main business activity of Rapier Pharmaceutical is trade. In detail, this covers retail trading.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GTradeG2Retail TradingLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Rapier Pharmaceutical Private Limited FY 2025 filings available

Rapier Pharmaceutical Private Limited reported revenue of ₹12.29 Lakh (down 16% YoY) for FY 2025.

Revenue · FY 2025
₹12.29 Lakh ▼ 16%
Net loss · FY 2025
₹4,770 margin -0.4%
EBITDA · FY 2025
₹25,500 margin 2.1%

Compounded Annual Growth Rate (CAGR) of Rapier Pharmaceutical Private Limited

Revenue CAGR growth
1 year
▼ 16%
3 years · compounded
▼ 11%
5 years · compounded
▼ 10%
EBITDA CAGR growth
1 year
▲ 309%
3 years · compounded
▲ 42%
5 years · compounded
▲ 54%

Revenue has declined at a compounded annual rate (CAGR) of 10% over five years, including a 16% fall in the latest year. EBITDA rose 309% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Rapier Pharmaceutical Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹25,500••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)-₹4,770••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Rapier Pharmaceutical Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin2.1%••••••••••••••••
Net Profit Margin-0.4%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Rapier Pharmaceutical are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Board of Directors of Rapier Pharmaceutical Private Limited

Rapier Pharmaceutical has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Hanishbhai Mansukhlal BuddhdevDirector16 Jul 201214 Years 3 MonthsCurrent
Jitendrakumar Jayvantbhai PanchamiyaDirector09 May 201115 Years 5 MonthsCurrent
Dharmesh ShahDirector09 May 201115 Years 5 MonthsCurrent

Peer Comparison of Rapier Pharmaceutical Private Limited

Rapier Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Retail Trading). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Genie Mensch Private Limited₹12.3 Lakh (FY 2024)••••••••31.0%••••Kolkata, West Bengal, India
Hitesh Organics Private Limited₹12.3 Lakh (FY 2025)••••••••-42.0%••••Patancheru, Telangana, India
KSP Multitech Private Limited₹12.3 Lakh (FY 2019)••••••••24.0%••••Bhubaneswar, Odisha, India
Arjun Tyres Private Limited₹12.3 Lakh (FY 2021)••••••••-14.0%••••Pune, Maharashtra, India
Mridul Cultivation Private Limited₹12.29 Lakh (FY 2025)••••••••-87.0%••••New Delhi, Delhi, India
Rapier Pharmaceutical Private Limited this company₹12.29 Lakh (FY 2025)••••••••-16.0%••••Rajkot, Gujarat, India
Zeegra Technologies Private Limited₹12.29 Lakh (FY 2021)••••••••-24.0%••••Bangalore, Karnataka, India
Dreamine Pariwar Sales Private Limited₹12.29 Lakh (FY 2020)••••••••••••New Delhi, Delhi, India
Gupta Spices Private Limited₹12.29 Lakh (FY 2024)••••••••114.0%••••West Bengal, India
Ipjacket Technology India Private Limited₹12.28 Lakh (FY 2024)••••••••-18.0%••••Varanasi, Uttar Pradesh, India
Unixes (OPC) Private Limited₹12.28 Lakh (FY 2022)••••••••-35.0%••••Delhi, India

Peers are the five companies nearest above and the five nearest below Rapier Pharmaceutical by revenue in the same principal business activity (Retail Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Rapier Pharmaceutical Private Limited

Rapier Pharmaceutical Private Limited is audited by VIJAY POPAT & ASSOCIATES for the financial year 2017.

NameStatusAppointment DateCessation Date
VIJAY POPAT & ASSOCIATESLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Rapier Pharmaceutical Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Rapier Pharmaceutical Private Limited

Rapier Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Rapier Pharmaceutical Private Limited

Employment history and EPFO contributions of people linked to Rapier Pharmaceutical.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Rapier Pharmaceutical Private Limited

Rapier Pharmaceutical Private Limited has 4 board changes on record since 2011: 3 appointments and 1 cessation. The latest: Rajubhai Vaghela ceased to be Director on 20 Nov 2018.

AGM
Rapier Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Rapier Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Ceased
Rajubhai Vaghela ceased to be Director.
Appointed
Hanishbhai Mansukhlal Buddhdev was appointed as Director.
Appointed
Dharmesh Shah was appointed as Director.
Appointed
Jitendrakumar Jayvantbhai Panchamiya was appointed as Director.
Incorporation
09 May 2011
Rapier Pharmaceutical Private Limited was registered on 09 May 2011 with Roc Ahmedabad & aged 15 years 5 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Rapier Pharmaceutical Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Rapier Pharmaceutical Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Rapier Pharmaceutical Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Rapier Pharmaceutical Private Limited

Rapier Pharmaceutical has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
24AAFCR3378A1ZNGujaratActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Rapier Pharmaceutical Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rapier Pharmaceutical Private Limited

Rapier Pharmaceutical is an active private limited company based in Rajkot, Gujarat, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 09 May 2011 (15+ years old) and is registered under CIN U24230GJ2011PTC065359.

Rapier Pharmaceutical reported revenue of ₹12.29 Lakh for FY 2025 (down 16% YoY).

Rapier Pharmaceutical has 3 current directors:

Rapier Pharmaceutical reported a net loss of ₹4,770 (net margin -0.4%) and EBITDA of ₹25,500 (EBITDA margin 2.1%) for FY 2025, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Rapier Pharmaceutical is -11% over three years and -10% over five years. In the latest year (FY 2025) revenue fell 16%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Rapier Pharmaceutical is 24AAFCR3378A1ZN, registered in Gujarat.

The CIN (Corporate Identification Number) of Rapier Pharmaceutical is U24230GJ2011PTC065359. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Rapier Pharmaceutical was incorporated on 09 May 2011, making it 15+ years old. It is registered with the Registrar of Companies, Ahmedabad.

The peers of Rapier Pharmaceutical by revenue are Genie Mensch Private Limited, Hitesh Organics Private Limited, KSP Multitech Private Limited, Arjun Tyres Private Limited, Mridul Cultivation Private Limited and 5 more, all in the same principal business activity (Retail Trading).

Rajubhai Vaghela ceased to be Director on 20 Nov 2018. Hanishbhai Mansukhlal Buddhdev was appointed as Director on 16 Jul 2012. Dharmesh Shah was appointed as Director on 09 May 2011. Rapier Pharmaceutical has 4 board changes on record in total.

The registered office of Rapier Pharmaceutical is at Shop No – 9 Upper Level Orbit Centre Moti Tanki Chowk, Rajkot, Gujarat, India – 360001.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available